Jaladi Himaja* and Battu Rakesh


Background: Stroke continues to be one of the leading causes of mortality and morbidity worldwide. Each year, stroke occurs in 30.9 million individuals worldwide and is responsible for ∼4 million deaths. Stroke is a disease of multifactorial aetiology that may develop as an end state in patients with serious vascular conditions—most notably, uncontrolled arterial hypertension. Apart from death, the greatest burden of stroke is serious long-term physical and mental disability. Stroke has deleterious effects on quality of life. Chronic arterial hypertension is the most significant modifiable risk factor for stroke. Other risk factors include diabetes mellitus, dyslipidaemia, smoking, alcohol consumption, atrial fibrillation. Treatment of elevated blood pressure during acute stroke must balance the theoretical risk of worsening the stroke due to reduced cerebral perfusion against the benefits of lowering blood pressure (reduced risk of haemorrhage, cerebral oedema, and other end-organ damage). Study of risk factors and drug-prescribing pattern can give insight into the trends in using the drugs in cerebrovascular stroke in treating their co-morbid conditions. The knowledge of drug utilization pattern can lead us towards the rational drug use and help to take measures to improve prescribing habits. Risk factors modification remains as the principal aspect of care for stroke prevention. Understanding of risk factors has advanced and several options are now available to treat modifiable risk factors. However, effective treatment remains a challenging task in clinical practice. Objectives: Primary: To study the clinical profile and prevalence of cerebrovascular stroke. Secondary: To evaluate the risk factors and drug utilization pattern in cerebrovascular stroke. Study Design: A Cross Sectional study was carried out in the General Medicine Department, MIMS Teaching Hospital, Mandya, Karnataka, using a well-designed patient proforma. Results: In this study, among 70 cases of cerebrovascular stroke analysed, the incidence of stroke was more common in male n=50 (60.6%) and n=20 (39.4%) were females. In this study 2 types of stroke was identified, 59 Ischemic stroke and 11 haemorrhagic stroke patients. Most of the patients diagnosed with stroke are in age group of 61-70 (38.57%). The most common co-morbid conditions were hypertension 34 (48.57%), diabetes mellitus 8 (11.42%) and a combination of hypertension, diabetes, dyslipidaemia 12 (17.14%) patients. The prescription pattern of various drugs were found to be as – antiplatelet drugs 59 (84.28%), anti-hyperlipidemic drugs 70 (100%), anti-diabetics 38(54.28%) antibiotics 57 (81.42%), anti-anginal drugs 25 (35.71%), antihypertensives 70 (100%), anticoagulants 12 (17.14%), diuretics 45 (64.28%) and bronchodilators 25 (35.71%). The average number of drugs per prescription was found to be 7.55. The most commonly prescribed drug classes in cerebrovascular stroke were anti-hyperlipidemic drugs, anti-hypertensives, antiplatelet drugs. Conclusion: The incidence of stroke was more common in male compared to female. Diabetes Mellitus, Hypertension, Hyperlipidaemia, Smoking and alcohol consumption are the risk factors for developing cerebrovascular stroke. Effective treatment in stroke remains a challenging task in clinical practice. Identifying and modifying key risk factors is crucial to reducing the morbidity and mortality of stroke. Computed tomography remains an appropriate imaging technique in the early assessment of most stroke patients.

Keywords: Cerebrovascular stroke, Arterial Hypertension, Atrial Fibrillation, Dyslipidaemia, Drug Utilization pattern, Computed Tomography.

[Full Text Article]


Forgot Password  |  Register


Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Tanima Debnath Sarkar

Download Article : Click here

News & Updation


    OCTOBER 2021 Issue has been successfully launched on 1 October 2021

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 5.467 to 6.044, due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.


UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS


Copyright From

Covering Letter

                        Author Instruction